Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson’s disease

Cited by (874)

Items 101–200 of 874

1. Lateralisation in Parkinson disease
   Peter Franz Riederer, K. A. Jellinger, Pierre Luc Kolber, Géraldine Hipp, Jeswinder Sian‐Hülsmann, Rejko Krüger · 2018 · Cell and Tissue Research
2. The Potential of L-Type Calcium Channels as a Drug Target for Neuroprotective Therapy in Parkinson's Disease
   Birgit Liss, Jörg Striessnig · 2019 · The Annual Review of Pharmacology and Toxicology
3. The usual suspects, dopamine and alpha‐synuclein, conspire to cause neurodegeneration
   Danielle E. Mor, Malcolm J. Daniels, Harry Ischiropoulos · 2019 · Movement Disorders
4. Activation of TGR5 with INT-777 attenuates oxidative stress and neuronal apoptosis via cAMP/PKCε/ALDH2 pathway after subarachnoid hemorrhage in rats
   Gang Zuo, Tongyu Zhang, Lei Huang, Camila Araujo, Jun Peng, Zachary D. Travis, Takeshi Okada, Umut Ocak, Guangyu Zhang, Jiping Tang et al. · 2019 · Free Radical Biology and Medicine
5. Iron homeostasis imbalance and ferroptosis in brain diseases
   Haining Long, Wangshu Zhu, Liming Wei, Jungong Zhao · 2023 · MedComm
6. Alterations to the Intestinal Microbiome and Metabolome ofPimephales promelasandMus musculusFollowing Exposure to Dietary Methylmercury
   Kristin M. Nielsen, Yan Zhang, Thomas E. Curran, Jason T. Magnuson, Barney J. Venables, Katherine E. Durrer, Michael S. Allen, Aaron P. Roberts · 2018 · Environmental Science & Technology
7. Role of ferroptosis in neurological diseases
   Min-Yi Yao, Tao Liu, Liang Zhang, Mingjian Wang, Yong Yang, Jing Gao · 2021 · Neuroscience Letters
8. Quantitative analysis of interactive behavior of mitochondria and lysosomes using structured illumination microscopy
   Qixin Chen, Xintian Shao, Mingang Hao, Hongbao Fang, Ruilin Guan, Zhiqi Tian, Miaoling Li, Chenran Wang, Liang‐Nian Ji, Hui Chao et al. · 2020 · Biomaterials
9. The interplay of dopamine metabolism abnormalities and mitochondrial defects in the pathogenesis of schizophrenia
   Haiyun Xu, Fan Yang · 2022 · Translational Psychiatry
10. Key genes and convergent pathogenic mechanisms in Parkinson disease
    Robert Coukos, Dimitri Krainc · 2024 · Nature reviews. Neuroscience
11. Lewy Body–like Inclusions in Human Midbrain Organoids Carrying Glucocerebrosidase and α‐Synuclein Mutations
    Junghyun Jo, Lin Yang, Hoang‐Dai Tran, Weonjin Yu, Alfred Xuyang Sun, Ya Yin Chang, Byung Chul Jung, Seung‐Jae Lee, Tzuen Yih Saw, Bin Xiao et al. · 2021 · Annals of Neurology
12. LRRK2 inhibition prevents endolysosomal deficits seen in human Parkinson's disease
    Emily M. Rocha, Briana R. De Miranda, Sandra L. Castro, Robert E. Drolet, Nathan Galen Hatcher, Lihang Yao, Sean M. Smith, Matthew T. Keeney, Roberto Di Maio, Julia Kofler et al. · 2019 · Neurobiology of Disease
13. The DJ1-Nrf2-STING axis mediates the neuroprotective effects of Withaferin A in Parkinson’s disease
    Miao Zhao, Bingwei Wang, Chenyu Zhang, Zhijie Su, Bingbing Guo, Yun Zhao, Ruimao Zheng · 2021 · Cell Death and Differentiation
14. Astrocyte-specific DJ-1 overexpression protects against rotenone-induced neurotoxicity in a rat model of Parkinson's disease
    Briana R. De Miranda, Emily M. Rocha, Qing Bai, Amina El Ayadi, David Hinkle, Edward A. Burton, J. Timothy Greenamyre · 2018 · Neurobiology of Disease
15. Cav2.3 channels contribute to dopaminergic neuron loss in a model of Parkinson’s disease
    Julia Benkert, Simon Heß, Shoumik Roy, Dayne A. Beccano-Kelly, Nicole Burkert, Johanna Duda, Carsten Simons, Komal Patil, Aisylu Gaifullina, Nadja Mannal et al. · 2019 · Nature Communications
16. Interactions of dopamine, iron, and alpha-synuclein linked to dopaminergic neuron vulnerability in Parkinson's disease and Neurodegeneration with Brain Iron Accumulation disorders
    Rachel M. Wise, Annika Wagener, Urban M. Fietzek, Thomas Klopstock, Eugene V. Mosharov, Fabio Andrea Zucca, David Sulzer, Luigi Zecca, Lena F. Burbulla · 2022 · Neurobiology of Disease
17. Proteasome-targeted nanobodies alleviate pathology and functional decline in an α-synuclein-based Parkinson’s disease model
    Diptaman Chatterjee, Mansi A. Bhatt, David Butler, Erwin De Genst, Christopher Martin Dobson, Anne C. Messer, Jeffrey H. Kordower · 2018 · npj Parkinson s Disease
18. Melatonin inhibits lung cancer development by reversing the Warburg effect via stimulating the SIRT3/PDH axis
    Xiangyun Chen, Bingjie Hao, Dan Xiao Li, Russel Joseph Reiter, Yidong Bai, Baigenzhin Abay, Guojie Chen, Shumeng Lin, Tiansheng Zheng, Yanbei Ren et al. · 2021 · Journal of Pineal Research
19. α-Synuclein pathology disrupts mitochondrial function in dopaminergic and cholinergic neurons at-risk in Parkinson’s disease
    Fanni F. Geibl, Martin T. Henrich, Zhong Xie, Enrico Zampese, Jun Ueda, Tatiana Tkatch, David L. Wokosin, Elena Nasiri, Constantin A. Grotmann, Valina Lynn Dawson et al. · 2024 · Molecular Neurodegeneration
20. Selective vulnerability in α-synucleinopathies
    Javier Alegre‐Abarrategui, Katherine R. Brimblecombe, Rosalind F. Roberts, Elisavet Velentza‐Almpani, Bension Shlomo Tilley, Nora Bengoa‐Vergniory, Christos Proukakis · 2019 · Acta Neuropathologica
21. Dietary Antioxidants and Parkinson’s Disease
    Hana Park, Amy Cameron Ellis · 2020 · Antioxidants
22. Glucose metabolism impairment in Parkinson’s disease
    Chengcheng Dai, Changhong Tan, Lili Zhao, Yi Liang, Guohui Liu, Hang Liu, Yuke Zhong, Zhihui Liu, Lijuan Mo, Xi Liu et al. · 2023 · Brain Research Bulletin
23. Experimental models of Parkinson's disease: Challenges and Opportunities
    Roshan Lal, Aditi Singh, Shivam watts, Kanwaljit Chopra · 2024 · European Journal of Pharmacology
24. Regulatory Activities of Dopamine and Its Derivatives toward Metal-Free and Metal-Induced Amyloid-β Aggregation, Oxidative Stress, and Inflammation in Alzheimer’s Disease
    Eunju Nam, Jeffrey S. Derrick, Seunghee Lee, Juhye Kang, Jiyeon Han, Shin Jung C. Lee, Su Wol Chung, Mi Hee Lim · 2018 · ACS Chemical Neuroscience
25. LRRK2 and α-Synuclein: Distinct or Synergistic Players in Parkinson’s Disease?
    Darren M. O’Hara, Grishma N. Pawar, Suneil Kumar Kalia, Lorraine V. Kalia · 2020 · Frontiers in Neuroscience
26. DJ-1 in neurodegenerative diseases: Pathogenesis and clinical application
    Maoxin Huang, Shengdi Chen · 2021 · Progress in Neurobiology
27. Human pluripotent stem cell–derived models and drug screening in CNS precision medicine
    M. Catarina Silva, Stephen J. Haggarty · 2019 · Annals of the New York Academy of Sciences
28. p38 MAPK-DRP1 signaling is involved in mitochondrial dysfunction and cell death in mutant A53T α-synuclein model of Parkinson's disease
    Chen Gui, Yixian Ren, Jialong Chen, Xian Guo Wu, Kanmin Mao, Huihui Li, Honglin Yu, Fei Zou, Wenjun Li · 2019 · Toxicology and Applied Pharmacology
29. Midbrain Organoids: A New Tool to Investigate Parkinson’s Disease
    Lisa M. Smits, Jens Christian Schwamborn · 2020 · Frontiers in Cell and Developmental Biology
30. The Convergence of Alpha-Synuclein, Mitochondrial, and Lysosomal Pathways in Vulnerability of Midbrain Dopaminergic Neurons in Parkinson’s Disease
    Georgia Minakaki, Dimitri Krainc, Lena F. Burbulla · 2020 · Frontiers in Cell and Developmental Biology
31. Parkin regulates amino acid homeostasis at mitochondria-lysosome (M/L) contact sites in Parkinson’s disease
    Wesley Peng, Leonie F. Schröder, Pingping Song, Yvette C. Wong, Dimitri Krainc · 2023 · Science Advances
32. Ferroptosis and Iron Homeostasis: Molecular Mechanisms and Neurodegenerative Disease Implications
    Nurzhan Abdukarimov, Kamilya Kokabi, Jeannette Kunz · 2025 · Antioxidants
33. Preserving Lysosomal Function in the Aging Brain: Insights from Neurodegeneration
    Peng, Wesley, Minakaki, Georgia, Nguyen, Maria, Krainc, Dimitri · 2019 · Neurotherapeutics
34. Iron overload is accompanied by mitochondrial and lysosomal dysfunction in WDR45 mutant cells
    Philip Seibler, Lena F. Burbulla, Marija Dulović, Simone Zittel, Johanne Heine, T. Schmidt, Franziska Rudolph, Ana Westenberger, Aleksandar Raković, Alexander Maximilian Münchau et al. · 2018 · Brain
35. Selective neuronal vulnerability in Parkinson's disease
    Patricia González‐Rodríguez, Enrico Zampese, Dalton James Surmeier · 2020 · Progress in brain research
36. Graphdiyne as Electrode Material: Tuning Electronic State and Surface Chemistry for Improved Electrode Reactivity
    Shuyue Guo, Hailong Yan, Fei Wu, Lijun Zhao, Ping Yu, Huibiao Liu, Yuliang Li, Lanqun Mao · 2017 · Analytical Chemistry
37. Calcium, Bioenergetics, and Parkinson’s Disease
    Zampese, Enrico, Surmeier, D. James · 2020 · Cells
38. Can Interactions Between α-Synuclein, Dopamine and Calcium Explain Selective Neurodegeneration in Parkinson's Disease?
    Michael R. Post, Ori J. Lieberman, Eugene V. Mosharov · 2018 · Frontiers in Neuroscience
39. Noxious Iron–Calcium Connections in Neurodegeneration
    M. Núñez, C. Hidalgo · 2019 · Frontiers in Neuroscience
40. Microbiome, Parkinson’s Disease and Molecular Mimicry
    Fabiana Miraglia, Emanuela Colla · 2019 · Cells
41. Targeting α-Synuclein for PD Therapeutics: A Pursuit on All Fronts
    Margaux Teil, Marie-Laure Arotçarena, Emilie Faggiani, Florent Laferrière, Erwan Bézard, Benjamin Dehay · 2020 · Biomolecules
42. Therapeutic Insights on Ferroptosis in Parkinson's disease
    Komal Thapa, Heena Khan, Neha Kanojia, Thakur Gurjeet Singh, Amarjot Kaur, Gagandeep Kaur · 2022 · European Journal of Pharmacology
43. Nanozyme-based strategies for efficient theranostics of brain diseases
    Ran Xu, Sijie Zhang, Peixia Wang, Ruofei Zhang, Peihua Lin, Yang Wang, Lizeng Gao, Hui Wei, Xiaodong Zhang, Daishun Ling et al. · 2023 · Coordination Chemistry Reviews
44. Covalent Modification and Regulation of the Nuclear Receptor Nurr1 by a Dopamine Metabolite
    John M. Bruning, Yan Wang, Francesca Oltrabella, Boxue Tian, Svetlana A. Kholodar, Harrison Liu, Paulomi Bhattacharya, Su Guo, James M. Holton, Robert J. Fletterick et al. · 2019 · Cell chemical biology
45. Predicting protein submitochondrial locations by incorporating the pseudo-position specific scoring matrix into the general Chou's pseudo-amino acid composition
    Wenying Qiu, Shan Li, Xiaowen Cui, Zhaomin Yu, Minghui Wang, Junwei Du, Yanjun Peng, Bin Yu · 2018 · Journal of Theoretical Biology
46. Crosstalk between Nrf2 signaling and mitochondrial function in Parkinson's disease
    Navneet Ammal Kaidery, Manuj Ahuja, Bobby Thomas · 2019 · Molecular and Cellular Neuroscience
47. Neurodevelopmental Toxicity of Polystyrene Nanoplastics in Caenorhabditis elegans and the Regulating Effect of Presenilin
    Qianyun Liu, Chunxiang Chen, Mengting Li, Jia Ke, Yichen Huang, Yuefeng Bian, Shufen Guo, Yang Wu, Yan Han, Mingyuan Liu · 2020 · ACS Omega
48. Calcium Homeostasis in Parkinson’s Disease: From Pathology to Treatment
    Jingxian Zhang, Qingqing Shen, Yue Ma, Lin Liu, Wenting Jia, Leilei Chen, Junxia Xie · 2022 · Neuroscience Bulletin
49. The Ferroptosis Inhibitor Liproxstatin-1 Ameliorates LPS-Induced Cognitive Impairment in Mice
    Yang Li, Miao Sun, Fuyang Cao, Yu Chen, Linlin Zhang, Hao Li, Jiangbei Cao, Jie Young Song, Yulong Ma, Weidong Mi et al. · 2022 · Nutrients
50. Spatiotemporally mapping temperature dynamics of lysosomes and mitochondria using cascade organelle-targeting upconversion nanoparticles
    Xiangjun Di, Dejiang Wang, Qian Peter Su, Yongtao Liu, Jiayan Liao, Mahnaz Maddahfar, Jiajia Zhou, Dayong Jin · 2022 · Proceedings of the National Academy of Sciences
51. PARK7/DJ-1 in microglia: implications in Parkinson’s disease and relevance as a therapeutic target
    Frida Lind‐Holm Mogensen, Andrea Scafidi, Aurélie Poli, Alessandro Michelucci · 2023 · Journal of Neuroinflammation
52. Thioredoxin-Interacting Protein (TXNIP) Regulates Parkin/PINK1-mediated Mitophagy in Dopaminergic Neurons Under High-glucose Conditions: Implications for Molecular Links Between Parkinson’s Disease and Diabetes
    Cunjin Su, Zhu Shen, Ru-Xiao Cui, Ya Huang, Delai Xu, Fenglun Zhao, Jie Pan, Ai-Ming Shi, Tong Liu, Yunli Yu · 2020 · Neuroscience Bulletin
53. The role of dopamine in NLRP3 inflammasome inhibition: Implications for neurodegenerative diseases
    Elena Possemato, Livia La Barbera, Annalisa Nobili, Paraskevi Krashia, Marcello D’Amelio · 2023 · Ageing Research Reviews
54. Mitochondrial function and autophagy: integrating proteotoxic, redox, and metabolic stress in Parkinson's disease
    Jianhua Zhang, Matilda Lillian Culp, Jason Craver, Victor M. Darley-Usmar · 2018 · Journal of Neurochemistry
55. Loss of Brain Norepinephrine Elicits Neuroinflammation-Mediated Oxidative Injury and Selective Caudo-Rostral Neurodegeneration
    Sheng Song, Lulu Jiang, Esteban A. Oyarzabal, Belinda C. Wilson, Zibo Li, Yen‐Yu Ian Shih, Qingshan Wang, Jau‐Shyong Hong · 2018 · Molecular Neurobiology
56. Multienzymatic Antioxidant Activity of Manganese-Based Nanoparticles for Protection against Oxidative Cell Damage
    Yang Zhang, Lixia Chen, Ruimeng Sun, Ruijuan Lv, Ting Du, Yuhan Li, Xinming Zhang, Rongtian Sheng, Yanfei Qi · 2022 · ACS Biomaterials Science & Engineering
57. Boronic acid sensors with double recognition sites: a review
    Zhancun Bian, Aiqin Liu, Ying Li, Guiqian Fang, Qingqiang Yao, Guimin Zhang, Zhongyu Wu · 2019 · The Analyst
58. Trichloroethylene, a ubiquitous environmental contaminant in the risk for Parkinson's disease
    Briana R. De Miranda, J. Timothy Greenamyre · 2020 · Environmental Science Processes & Impacts
59. Unveiling the Role of DJ‐1 Protein in Vesicular Storage and Release of Catecholamine with Nano/Micro‐Tip Electrodes
    Qingwei Yue, Xianchan Li, Fei Wu, Wenliang Ji, Yue Zhang, Ping Yu, Meining Zhang, Wenjie Ma, Ming Wang, Lanqun Mao · 2020 · Angewandte Chemie International Edition
60. Genetic perspective on the synergistic connection between vesicular transport, lysosomal and mitochondrial pathways associated with Parkinson’s disease pathogenesis
    Stefanie Smolders, Christine Van Broeckhoven · 2020 · Acta Neuropathologica Communications
61. Insights into the Effects of Mesenchymal Stem Cell-Derived Secretome in Parkinson’s Disease
    Michele d’Angelo, Annamaria Cimini, Vanessa Castelli · 2020 · International Journal of Molecular Sciences
62. Neuroprotective Effects of Resveratrol in In vivo and In vitro Experimental Models of Parkinson’s Disease: a Systematic Review
    Michele Goulart dos Santos, Lúcia Emanueli Schimith, Corinne André‐Miral, Ana Luíza Muccillo-Baisch, Bruno Dutra Arbo, Mariana Appel Hort · 2022 · Neurotoxicity Research
63. Glucocerebrosidase-associated Parkinson disease: Pathogenic mechanisms and potential drug treatments
    Matthew E. Gegg, Elisa Menozzi, Anthony H.V. Schapira · 2022 · Neurobiology of Disease
64. A review: Progress and trend advantage of dopamine electrochemical sensor
    Abdul Karim, M. Yasser, Ahyar Ahmad, Hasnah Natsir, Abdul Wahid Wahab, St. Fauziah, Paulina Taba, Irham Pratama, Rosalin, Arini Rajab et al. · 2024 · Journal of Electroanalytical Chemistry
65. Unifying Hypothesis of Dopamine Neuron Loss in Neurodegenerative Diseases: Focusing on Alzheimer's Disease
    Paraskevi Krashia, Annalisa Nobili, Marcello D’Amelio · 2019 · Frontiers in Molecular Neuroscience
66. Induced pluripotent stem cells: a tool for modeling Parkinson’s disease
    Anindita Bose, Gregory A. Petsko, Lorenz Studer · 2022 · Trends in Neurosciences
67. Disruption of lysosomal proteolysis in astrocytes facilitates midbrain organoid proteostasis failure in an early-onset Parkinson’s disease model
    Gustavo Morrone Parfitt, Elena Coccia, Camille Goldman, Kristen R. Whitney, Ricardo Reyes, Lily Sarrafha, Ki Hong Nam, Soha Sohail, Drew R. Jones, John F. Crary et al. · 2024 · Nature Communications
68. Disorders of Endogenous and Exogenous Antioxidants in Neurological Diseases
    Izabela Korczowska-Łącka, Bartosz Kazimierz Słowikowski, Thomas Piekut, Mikołaj Hurła, Natalia Banaszek, Oliwia Szymanowicz, Paweł Piotr Jagodziński, Wojciech P. Kozubski, Agnieszka Permoda-Pachuta, Jolanta Dorszewska · 2023 · Antioxidants
69. α-Synuclein-Dependent Calcium Entry Underlies Differential Sensitivity of Cultured SN and VTA Dopaminergic Neurons to a Parkinsonian Neurotoxin
    Ori J. Lieberman, Se Joon Choi, Ellen Kanter, Anastasia Saverchenko, Micah D. Frier, Giulia M. Fiore, Min Wu, Jyothisri Kondapalli, Enrico Zampese, Dalton James Surmeier et al. · 2017 · eNeuro
70. Protective role of mitophagy on microglia-mediated neuroinflammatory injury through mtDNA-STING signaling in manganese-induced parkinsonism
    Lu Yang, Liang Gao, Yuqing Yang, Dihang Shi, Zhipeng Zhang, Xiaobai Wang, Ying Huang, Jie Wu, Jia Meng, Hong Li et al. · 2025 · Journal of Neuroinflammation
71. Therapeutic Potential of a Prolyl Hydroxylase Inhibitor FG-4592 for Parkinson’s Diseases in Vitro and in Vivo: Regulation of Redox Biology and Mitochondrial Function
    Xuan Li, Xinxin Cui, Yajing Chen, Tingting Wu, Huaxi Xu, Huiyong Yin, Yun‐Cheng Wu · 2018 · Frontiers in Aging Neuroscience
72. α-Synuclein in Parkinson's disease and advances in detection
    Rong Chen, Xuan Gu, Xiaoying Wang · 2022 · Clinica Chimica Acta
73. Deficiency in endocannabinoid synthase DAGLB contributes to early onset Parkinsonism and murine nigral dopaminergic neuron dysfunction
    Zhenhua Liu, Nannan Yang, Jie Dong, Wotu Tian, Lisa Chang, Jinghong Ma, Jifeng Guo, Jieqiong Tan, Ao Dong, Kaikai He et al. · 2022 · Nature Communications
74. Neurotrophic factors for disease-modifying treatments of Parkinson's disease: gaps between basic science and clinical studies
    Piotr Chmielarz, Märt Saarma · 2020 · Pharmacological Reports
75. Recent insights into the microRNA-dependent modulation of gliomas from pathogenesis to diagnosis and treatment
    Mafi, Alireza, Rahmati, Atefe, Babaei Aghdam, Zahra, Salami, Raziyeh, Salami, Marziyeh, Vakili, Omid, Aghadavod, Esmat · 2022 · Cellular & Molecular Biology Letters
76. Mitochondrially-targeted treatment strategies
    Luiz H. M. Bozi, Juliane C. Campos, Vanessa O. Zambelli, Nikolas Dresch Ferreira, Julio Cesar Batista Ferreira · 2019 · Molecular Aspects of Medicine
77. Associations Between Diabetes Mellitus and Neurodegenerative Diseases
    Leszek Szablewski · 2025 · International Journal of Molecular Sciences
78. Pathogenic Pathways in Early-Onset Autosomal Recessive Parkinson's Disease Discovered Using Isogenic Human Dopaminergic Neurons
    Tim Ahfeldt, Alban Ordureau, Christina Bell, Lily Sarrafha, Chicheng Sun, Silvia Piccinotti, Tobias Graß, Gustavo Morrone Parfitt, João A. Paulo, Fumiki Yanagawa et al. · 2020 · Stem Cell Reports
79. Fucoxanthin Prevents 6‐OHDA‐Induced Neurotoxicity by Targeting Keap1
    Wei Wu, Hui Han, Jingwangwei Liu, Min Tang, Xiaoyu Wu, Xiaojun Cao, Tiantian Zhao, Yujia Lu, Tingting Niu, Juanjuan Chen et al. · 2021 · Oxidative Medicine and Cellular Longevity
80. Generation of caudal-type serotonin neurons and hindbrain-fate organoids from hPSCs
    Parvin Valiulahi, Vincencius Vidyawan, Lesly Puspita, Youjin Oh, Virginia Blessy Juwono, Panida Sittipo, Gilgi Friedlander, Dayana Yahalomi, Jong‐Woo Sohn, Yun Kyung Lee et al. · 2021 · Stem Cell Reports
81. Clinical, mechanistic, biomarker, and therapeutic advances in GBA1-associated Parkinson’s disease
    Xuxiang Zhang, Heng Wu, Beisha Tang, Jifeng Guo · 2024 · Translational Neurodegeneration
82. Mitochondria and α-Synuclein: Friends or Foes in the Pathogenesis of Parkinson’s Disease?
    Gaia Faustini, Federica Bono, Alessandra Valerio, Marina Pizzi, PierFranco Spano, Arianna Bellucci · 2017 · Genes
83. Effects of α-Synuclein-Associated Post-Translational Modifications in Parkinson’s Disease
    Songzhe He, Fushun Wang, Ken Kin Lam Yung, Shiqing Zhang, Shaogang Qu · 2021 · ACS Chemical Neuroscience
84. Oxidative stress and synaptic dysfunction in rodent models of Parkinson's disease
    Paola Imbriani, Giuseppina Martella, Paola Bonsi, Antonio Pisani · 2022 · Neurobiology of Disease
85. The Role of DJ-1 in Cellular Metabolism and Pathophysiological Implications for Parkinson’s Disease
    Pauline Mencke, Ibrahim Boussaad, Chiara Romano, Toshimori Kitami, Carole L. Linster, Rejko Krüger · 2021 · Cells
86. Parkinson’s disease-linked parkin mutation disrupts recycling of synaptic vesicles in human dopaminergic neurons
    Pingping Song, Wesley Peng, Véronique Sauvé, Rayan Fakih, Zhong Xie, Daniel Ysselstein, Talia Krainc, Yvette C. Wong, Niccolò Emanuele Mencacci, Jeffrey N. Savas et al. · 2023 · Neuron
87. α-Arbutin Protects Against Parkinson’s Disease-Associated Mitochondrial Dysfunction In Vitro and In Vivo
    Yaqi Ding, Deqin Kong, Tong Zhou, Naidi Yang, Chenqi Xin, Jiajia Xu, Qi Wang, Hang Zhang, Qiong Wu, Xiaomei Lü et al. · 2019 · NeuroMolecular Medicine
88. Multi-enzymatic activities of ultrasmall ruthenium oxide for anti-inflammation and neuroprotection
    Chenyao Wu, Xiuguo Han, Wei Feng, Zhonglong Liu, Lisong Chen, Bangguo Zhou, Yu Chen, Jianlin Shi · 2021 · Chemical Engineering Journal
89. PARK7 promotes repair in early steroid-induced osteonecrosis of the femoral head by enhancing resistance to stress-induced apoptosis in bone marrow mesenchymal stem cells via regulation of the Nrf2 signaling pathway
    Fei Zhang, Yanglin Yan, Wuxun Peng, Lei Wang, Tao Wang, Zhihong Xie, Hong Luo, Jian Zhang, Wentao Dong · 2021 · Cell Death and Disease
90. The role of tyrosine hydroxylase–dopamine pathway in Parkinson’s disease pathogenesis
    Zhidong Zhou, Wuan Ting Saw, Patrick Ho, Zhi Wei Zhang, Li Zeng, Ya Yin Chang, Alfred Xuyang Sun, Dong Rui Ma, Hong Yan Wang, Lei Zhou et al. · 2022 · Cellular and Molecular Life Sciences
91. Functional Mammalian Amyloids and Amyloid-Like Proteins
    Maria S. Rubel, Sergey A. Fedotov, Anastasia V. Grizel, Julia V. Sopova, Oksana A. Malikova, Yury O. Chernoff, Aleksandr A. Rubel · 2020 · Life
92. Neuroprotective mechanisms of ε-viniferin in a rotenone-induced cell model of Parkinson's disease: significance of SIRT3-mediated FOXO3 deacetylation
    Shuo Zhang, Yan Ma, Juan Feng · 2020 · Neural Regeneration Research
93. Back and to the Future: From Neurotoxin‐Induced to Human Parkinson's Disease Models
    Mikko Airavaara, Ilmari Parkkinen, Julia Konovalova, Katrina Albert, Piotr Chmielarz, Andrii Domanskyi · 2020 · Current Protocols in Neuroscience
94. GDNF / RET Signaling Pathway Activation Eliminates Lewy Body Pathology in Midbrain Dopamine Neurons
    Piotr Chmielarz, Şafak Er, Julia Konovalova, Laura Bandrés, Irena Hlushchuk, Katrina Albert, Anne E. Panhelainen, Kelvin C. Luk, Mikko Airavaara, Andrii Domanskyi · 2020 · Movement Disorders
95. Aldehyde dehydrogenase 2 in the spotlight: The link between mitochondria and neurodegeneration
    Romina Deza-Ponzio, Macarena Lorena Herrera, María José Bellini, Miriam B. Virgolini, Claudia Beatriz Hereñú · 2018 · NeuroToxicology
96. Twin CHCH Proteins, CHCHD2, and CHCHD10: Key Molecules of Parkinson’s Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia
    Yuzuru Imai, Hongrui Meng, Kahori Shiba‐Fukushima, Nobutaka Hattori · 2019 · International Journal of Molecular Sciences
97. Glucocerebrosidase deficiency promotes release of α-synuclein fibrils from cultured neurons
    Matthew E. Gegg, Guglielmo Verona, Anthony H.V. Schapira · 2020 · Human Molecular Genetics
98. A patient-based model of RNA mis-splicing uncovers treatment targets in Parkinson’s disease
    Ibrahim Boussaad, Carolin D. Obermaier, Zoé Hanss, Dheeraj Reddy Bobbili, Silvia Bolognin, Enrico Glaab, Katarzyna Wołyńska, Nicole Weisschuh, Laura De Conti, Caroline May et al. · 2020 · Science Translational Medicine
99. The catecholaldehyde hypothesis: where MAO fits in
    David S. Goldstein · 2019 · Journal of Neural Transmission
100. Plasmonic Coupling on an Optical Microfiber Surface: Enabling Single‐Molecule and Noninvasive Dopamine Detection
     Yunyun Huang, Pengwei Chen, Luyan Zhou, Jiaying Zheng, Haotian Wu, Jiaxuan Liang, Aoxiang Xiao, Jie Li, Bai‐Ou Guan · 2023 · Advanced Materials